Journal
PROGRESS IN NEUROLOGY AND PSYCHIATRY
Volume 23, Issue 3, Pages 26-33Publisher
JOHN WILEY & SONS LTD
DOI: 10.1002/pnp.544
Keywords
-
Categories
Ask authors/readers for more resources
Migraine is considered as one of the most debilitating neurological disorders but the success of the anti-calcitonin gene-related peptide (CGRP) therapies marks a new era in the treatment of migraine and has paved way for further research into the exact pathophysiology of migraine. Here, the authors discuss their literature review on the anti-CGRP therapies to examine the pathophysiology of migraine, with a focus on the possible role of CGRP and the safety and efficacy of monoclonal antibodies targeting it.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available